{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:37:23Z","timestamp":1769168243379,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.japh.2025.102937","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:44:22Z","timestamp":1759995862000},"page":"102937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in opioid use among adults with cardiovascular disease, 2001 \u2013 March 2020"],"prefix":"10.1016","volume":"66","author":[{"given":"Gi Eun","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9766-7711","authenticated-orcid":false,"given":"Andrew Y.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.japh.2025.102937_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain - United States, 2016 [published correction appears in MMWR Recomm Rep. 2016;65(11):295]","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.japh.2025.102937_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"issue":"12","key":"10.1016\/j.japh.2025.102937_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.17228","article-title":"Trends in prescription analgesic use among adults with musculoskeletal conditions in the United States, 1999-2016","volume":"2","author":"Stokes","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.japh.2025.102937_bib4","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/j.pain.0000000000002101","article-title":"Patterns of opioid analgesic use in the U.S., 2009 to 2018","volume":"162","author":"Woods","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.japh.2025.102937_bib5","series-title":"Drug Overdose Deaths in the United States, 2001\u20132021. NCHS Data Brief, No 457","author":"Spencer","year":"2022"},{"key":"10.1016\/j.japh.2025.102937_bib6","series-title":"Drug Overdose Deaths in the United States, 2003\u20132023. NCHS Data Brief, No 522","author":"Garnett","year":"2024"},{"issue":"13","key":"10.1016\/j.japh.2025.102937_bib7","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1161\/CIR.0000000000001007","article-title":"Opioid use and its relationship to cardiovascular disease and brain health: a presidential advisory from the American Heart Association","volume":"144","author":"Chow","year":"2021","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.japh.2025.102937_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jacc.2020.11.002","article-title":"Cardiovascular complications of opioid use: JACC state-of-the-art review","volume":"77","author":"Krantz","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.japh.2025.102937_bib9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10840-021-01072-1","article-title":"Effects of opioid receptor agonist and antagonist medications on electrocardiogram changes and presentation of cardiac arrhythmia: review article","volume":"63","author":"Etaee","year":"2022","journal-title":"J Interv Card Electrophysiol"},{"issue":"2","key":"10.1016\/j.japh.2025.102937_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2125.2008.03327.x","article-title":"Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro","volume":"67","author":"Fanoe","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.japh.2025.102937_bib11","series-title":"WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents","year":"2018"},{"issue":"3","key":"10.1016\/j.japh.2025.102937_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/phar.2488","article-title":"U.S. trends in prescription nonsteroidal anti-inflammatory drug use among patients with cardiovascular disease, 1988-2016","volume":"41","author":"Hwang","year":"2021","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.japh.2025.102937_bib25","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/cancers15030591","article-title":"Update on prevalence of pain in patients with cancer 2022: a systematic literature review and meta-analysis","volume":"15","author":"Snijders","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.japh.2025.102937_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1127636","article-title":"Comparison of the prevalence of opioid use among U.S. adults with cardiac conditions before and during the COVID-19 pandemic","volume":"11","author":"Weng","year":"2023","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.japh.2025.102937_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkab095","article-title":"Trends in opioid use among cancer patients in the United States: 2013-2018","volume":"6","author":"Chen","year":"2021","journal-title":"JNCI Cancer Spectr"},{"issue":"5","key":"10.1016\/j.japh.2025.102937_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.37765\/ajmc.2022.89141","article-title":"Patterns of opioid use in commercially insured patients with cancer","volume":"28","author":"Le","year":"2022","journal-title":"Am J Manag Care"},{"issue":"15","key":"10.1016\/j.japh.2025.102937_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.15585\/mmwr.mm7215a1","article-title":"Chronic pain among adults - united States, 2019-2021","volume":"72","author":"Rikard","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"10.1016\/j.japh.2025.102937_bib33","article-title":"Opioids compared to placebo or other treatments for chronic low-back pain","volume":"2013","author":"Chaparro","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.japh.2025.102937_bib34","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1001\/jamainternmed.2018.4273","article-title":"Frequency and associations of prescription nonsteroidal anti-inflammatory drug use among patients with a musculoskeletal disorder and hypertension, heart failure, or chronic kidney disease","volume":"178","author":"Bouck","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"7","key":"10.1016\/j.japh.2025.102937_bib35","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jpain.2019.01.003","article-title":"Eighteen-year trends in the prevalence of, and health care use for, noncancer pain in the United States: data from the Medical expenditure panel survey","volume":"20","author":"Nahin","year":"2019","journal-title":"J Pain"},{"issue":"4","key":"10.1016\/j.japh.2025.102937_bib36","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.anclin.2022.08.018","article-title":"Chronic pain considerations in patients with cardiovascular disease","volume":"40","author":"Layne-Stuart","year":"2022","journal-title":"Anesthesiol Clin"},{"key":"10.1016\/j.japh.2025.102937_bib38","series-title":"Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education. Relieving Pain in America: a Blueprint for Transforming Prevention, Care, Education, and Research","year":"2011"},{"issue":"10","key":"10.1016\/j.japh.2025.102937_bib39","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1177\/0898264320931665","article-title":"Trends in pain prevalence among adults aged 50 and older across Europe, 2004 to 2015","volume":"32","author":"Zimmer","year":"2020","journal-title":"J Aging Health"},{"issue":"4","key":"10.1016\/j.japh.2025.102937_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/J354v16n04_02","article-title":"Clinical pharmacokinetics of morphine","volume":"16","author":"Lugo","year":"2002","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"3","key":"10.1016\/j.japh.2025.102937_bib41","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.anclin.2019.04.007","article-title":"Geriatric pharmacology: an update","volume":"37","author":"Andres","year":"2019","journal-title":"Anesthesiol Clin"},{"issue":"7","key":"10.1016\/j.japh.2025.102937_bib42","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.japh.2025.102937_bib43","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jamainternmed.2017.7856","article-title":"Gabapentinoid use in the United States 2002 through 2015","volume":"178","author":"Johansen","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.japh.2025.102937_bib44","series-title":"HCUP Statistical Brief #245","article-title":"Geographic variation in substance-related inpatient stays across States and counties in the United States, 2013-2015","author":"Fingar","year":"2018"},{"issue":"3","key":"10.1016\/j.japh.2025.102937_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2217\/pmt.13.18","article-title":"Socioeconomic status and the course and consequences of chronic pain","volume":"3","author":"Bonathan","year":"2013","journal-title":"Pain Manag"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125006168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125006168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:55:32Z","timestamp":1769111732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319125006168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1544319125006168"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2025.102937","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in opioid use among adults with cardiovascular disease, 2001 \u2013 March 2020","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2025.102937","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"102937"}}